Proteomics 2026-10-20
proteomics studies the identities, amounts, modifications and associations of proteins in biological material. Measurements depend on extraction, detectability and reference condition; absence of a detected peptide is not proof that its protein is absent.
Pseudomonas syringae pv. tomato DC3000 is the name used for a well-studied bacterial strain in experimental interactions with tomato and Arabidopsis thaliana. The abbreviation pv. denotes pathovar, a classification related to pathogenic characteristics, while DC3000 identifies the particular strain. Those parts of the label carry more information than the species name Pseudomonas syringae alone.[ref]
The 2003 genome report described about 6.5 megabases of DNA, comprising one circular chromosome and two plasmids, with 5763 predicted open reading frames. The assembly and annotation created a reference for comparing molecular observations, rather than merely attaching a name to a culture.[ref] A predicted open reading frame is not automatically an experimentally established protein function.
In a 2011 plant-community experiment, this strain supplied a common challenge against which different bacterial colonists were compared. Both pathogen population and host disease symptoms were measured.[ref] Holding the challenge strain fixed makes differences between colonist treatments easier to interpret. It does not make the experiment representative of every Pseudomonas syringae strain or every host.
PTBP1 2026-10-20
A polypyrimidine-tract-binding protein with four RNA recognition motifs. Its splicing effects depend on site position, RNA geometry and other proteins; it is not exclusively a repressor.
PUMA Created 2026-10-20 Updated 2026-11-05
A proapoptotic BH3-only BCL-2-family protein induced in some p53 responses, contributing to mitochondrial apoptosis.
Pyridoxal phosphate 2026-11-05
Pyridoxal phosphate is the 5′-phosphate derivative of pyridoxal, a Vitamin B6 form whose ring carries a reactive aldehyde group. It serves as a coenzyme in amino acid chemistry. The phosphate-bearing substituent and the aldehyde have different roles: identifying one does not explain the reactivity of the other.[ref]
An example is 1-aminocyclopropane-1-carboxylate synthase. In a 1990 experiment, chemical reduction with tritium-labelled reagent trapped the coenzyme attached to the enzyme. Subsequent protein digestion and sequencing localized the labelled active-site segment; acid hydrolysis released a modified lysine bearing the pyridoxyl group. This provided chemical evidence for the linkage, beyond observing that adding pyridoxal phosphate improves activity.[ref]
Rab GTPase Created 2026-10-20 Updated 2026-11-05
A Rab GTPase is a small GTP-binding protein that regulates membrane traffic. GDP- and GTP-bound states differ in their interactions with effectors, while exchange factors and GTPase-activating proteins regulate the cycle. Different Rabs act at different trafficking stages, helping organize compartment identity, motor recruitment and carrier targeting. Rab8a and Rab11a illustrate related switches with different preferred routes and partners. [ref]
Rabin8 Created 2026-10-20 Updated 2026-11-05
Rabin8 is a guanine-nucleotide exchange factor that activates Rab8a by promoting exchange of bound GDP for GTP. It links upstream trafficking signals to a Rab-controlled membrane-delivery pathway, including ciliary membrane formation. Its role is distinct from a GTPase-activating protein, which accelerates GTP hydrolysis. The exchange factor changes the state of the molecular switch rather than carrying all cargo itself. [ref]
Ralph Abraham Created 2026-10-13 Updated 2026-11-05
Coauthor of research on antibody unfolding and binding in force spectroscopy. The study connected molecular mechanical states with the interpretation of recognition measurements, rather than treating a measured binding event as independent of protein conformation.[ref]
Ramanujan S. Hegde Created 2026-10-18 Updated 2026-11-05
Researcher in protein targeting and membrane biogenesis. With Sichen Shao, Hegde analyzed insertion of membrane proteins at the endoplasmic reticulum, connecting protein properties with the machinery that handles them.[ref]
Figure 1.
Ramanujan S. Hegde
.
Ran 2026-11-05
Ran is a small GTPase involved in transport through the nuclear pore complex and in organization of microtubules. It switches between GDP- and GTP-bound states. The spatial organization of its regulators makes its nucleotide state informative about location, rather than simply reporting the total amount of the protein. [ref]
In nuclear import, a high nuclear Ran-GTP activity promotes release of cargo from transport receptors, while the cytosolic side supports recycling through a different nucleotide state. This directional cycle depends on separated regulator activities and a supply of chemical energy. Equalizing all conditions on both sides would remove the same spatial cue even if the total Ran abundance stayed fixed. [ref]
Rational protein design Created 2026-10-20 Updated 2026-11-05
Rational protein design proposes sequences or substitutions using structural, chemical or evolutionary information. A plausible model narrows the search but does not establish that the resulting protein folds, binds or catalyses as intended.
RB Created 2026-10-20 Updated 2026-11-05
The retinoblastoma tumour-suppressor protein, which restrains E2F-dependent proliferation when appropriately active. Regulation by cyclin-dependent kinases couples this restraint to cell-cycle signals.
RB pathway 2026-10-20
A regulatory system involving retinoblastoma protein and E2F-associated control of cell-cycle gene expression and entry into DNA replication.
R. Craig Cadwell Created 2026-10-20 Updated 2026-11-05
Deliberate or naturally induced generation of sequence changes. In experimental protein evolution the method determines the distribution of variants available for testing.
Reactive-center loop 2026-11-05
The reactive-center loop is a mobile segment of a serpin that presents a target peptide bond to a protease. For inhibitory serpins, attack on this segment initiates structural rearrangement that can trap the attacking enzyme. It is therefore both a recognition surface and part of a mechanical inhibitory mechanism.[ref]
Its exposure can itself be regulated. In antithrombin, a 1997 comparison of structures with a high-affinity heparin fragment linked activation to expulsion of partly inserted loop residues from the main beta sheet, making the loop more accessible.[ref]
Two uses of loop movement should be distinguished. Exposing the loop prepares an inhibitor for reaction; inserting the cleaved loop into the beta sheet participates in trapping the protease. Comparing these states explains why the same protein can differ greatly in inhibitory activity without changing its protein primary structure.[ref]
Reassortment 2026-11-05
Reassortment is the mixing of intact genetic segments from different parental viruses into progeny with a segmented genome. If parental viruses reproduce in the same cell, a progeny genome can inherit some segments from one parent and others from the other. This exchanges whole segment identities; it does not require a crossover within each RNA or DNA segment.
For a toy virus with three distinguishable segments, parents and allow the reassortant combination . Independent binary choice at each position gives possible combinations, including the two parental combinations. This is a combinatorial count; packaging compatibility and viability can prevent many combinations from appearing.
In a 1979 study, RNA oligonucleotide fingerprints and protein peptide maps suggested that an influenza strain retained some segments from earlier H1N1 viruses while other segments most likely came from an H3N2 parent. The unchanged H1N1 surface subtype therefore did not imply unchanged ancestry across the whole genome.[ref]
Receptor (biochemistry) Created 2026-10-13 Updated 2026-11-05
A biochemical receptor is a protein that recognizes a signal and couples its detection to a biological effect. Its binding partner is a ligand; recognition depends on compatible shape and chemical interactions at a binding site within the protein structure. Specificity is selective recognition, not a guarantee that only one ligand can bind. Binding also need not activate the receptor: a competing ligand may occupy it while preventing activation by another ligand. See Alberts et al., Molecular Biology of the Cell, 4th edition: protein binding and specificity.
Compare a cell-surface receptor, accessible to an extracellular ligand, with an intracellular receptor, whose ligand must reach the interior. A cell-surface receptor can detect a hydrophilic ligand without transporting it through the cell membrane. In contrast, some membrane-permeable signals reach intracellular receptors that regulate gene expression. Location and downstream coupling are separate distinctions: an ionotropic receptor directly gates an ion channel, whereas a metabotropic receptor works through intracellular signal transduction. See Clark, Douglas and Choi, Biology 2e, 9.1: receptor locations and mechanisms.
Receptor binding occupancy quantifies recognition separately from response. A dissociation constant measures binding in a specified equilibrium model; it does not by itself predict the cellular effect. This separation is useful when comparing signals that bind equally well but produce different responses, or when interpreting a binding experiment alongside a functional measurement.
A receptor phosphorylation assay asks whether, and how much, a specified receptor is modified by phosphorylation under defined conditions. It is distinct from a binding assay for receptor binding occupancy, a test of protein kinase activity on a supplied substrate, and a test of downstream signal transduction. Those measurements answer related but different questions.
For a Western blot implementation, compare matched samples with ligand omitted or added, detect a specified phosphorylated epitope, and separately detect total receptor abundance. Preserve the sampled state by stopping further enzyme reactions during sample preparation; otherwise protein kinase or protein phosphatase activity after sampling can change the result. A general anti-phosphotyrosine residue antibody recognizes many modified proteins; a site-selective antibody gives a narrower readout, but still needs Western blot antibody specificity controls.
Reason through the controls before interpreting the difference. Loss of the proposed signal after receptor-specific gene deletion supports protein identity. Treatment with a protein phosphatase, alongside preservation of the total-receptor signal, tests phosphate-dependent recognition. Western blot loading controls and Western blot transfer controls address sample recovery; a usable detection range addresses Western blot response saturation. Lower signal after perturbing protein kinase activity supports dependence on that perturbation, but alternative targets and altered receptor abundance can complicate the inference. These are proposed assay comparisons, not outcomes attributed to the historical membrane experiment.
Figure 1.
Controls connecting a receptor phosphorylation assay to a defensible inference
. Original reasoning diagram for a Western blot implementation. Separate comparisons address protein identity, phosphate-dependent epitope recognition, recovery and detection response. Boxes prescribe questions; they contain no measured bands, observed experimental outcomes or synthetic time course. Details.
An original idealized measurement model explains the normalization. Let be the retained number of receptor molecules, the fraction carrying the selected modified epitope, and fixed detection gains. After subtracting their respective backgrounds, suppose the phosphorylated and total-receptor signals lie in a linear response range:
Dividing by total receptor cancels under these assumptions. It differs from total-protein Western blot normalization, whose denominator includes many other proteins. For invented values , samples with and give and , but both give . Twice the phospho signal here means twice the retained receptor amount, with no change in fractional modification. Unequal recovery, changed epitope accessibility, nonzero uncorrected background or Western blot response saturation invalidates the cancellation. Unknown relative gains prevent reading an absolute modified fraction directly from the ratio.
Receptor tyrosine kinase Created 2026-10-14 Updated 2026-10-20
A receptor tyrosine kinase combines extracellular ligand recognition with an intracellular protein kinase protein domain. A membrane-spanning segment connects these parts across the cell membrane: the signal changes the intracellular machinery without requiring the ligand to enter the cytosol. The protein kinase transfers a phosphate group from ATP to selected tyrosine residues on proteins, including the receptor itself.[ref]
This architecture makes a reception event useful in two ways: it can change catalytic activity and assemble a local group of signaling proteins. Trans-autophosphorylation can create phosphotyrosine residues recognized by SH2 domains. Recruitment positions a downstream enzyme or relay protein near its partners. Neither every modified site nor every recruited protein has the same effect; association is a specific molecular connection, rather than a universal command to activate everything nearby.[ref]
Compare the epidermal growth factor receptor with the insulin receptor. Their common topology does not impose one activation geometry or make assembly equivalent to activity. The receptor phosphorylation assay consequently needs more than evidence that two protein chains associate.
Figure 1.
Receptor tyrosine kinase architecture and distinct activation mechanisms
. Original topology cartoons contrasting EGFR with the preassembled insulin receptor. Orange dots mark phosphotyrosine residues; S–S marks protein disulfide bonds. The EGFR panel separates asymmetric catalytic contact from partner-tail phosphorylation. Shapes, distances and drawn ligand counts are explanatory, rather than atomic structures or binding stoichiometry. Details.
Regulator of G protein signalling Created 2026-10-20 Updated 2026-11-05
A protein that accelerates GTP hydrolysis by an appropriate G protein alpha subunit, shortening its activated lifetime. Family and tissue specificity matter for therapeutic manipulation.